AR003436A1 - Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos. - Google Patents

Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos.

Info

Publication number: AR003436A1
Authority: AR; Argentina
Prior art keywords: molecules; ligands; nucleic acids; purified nucleic; seletine
Prior art date: 1995-06-14

Application number

ARP960103147A

Other languages

English (en)

Spanish (es)

Original Assignee

Gen Hospital Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-14

Filing date

1996-06-13

Publication date

1998-08-05

1996-06-13 Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp

1998-08-05 Publication of AR003436A1 publication Critical patent/AR003436A1/es

Links

239000003446 ligand Substances 0.000 title abstract 4
239000003814 drug Substances 0.000 title abstract 2
102000039446 nucleic acids Human genes 0.000 title abstract 2
108020004707 nucleic acids Proteins 0.000 title abstract 2
150000007523 nucleic acids Chemical class 0.000 title abstract 2
239000013598 vector Substances 0.000 title abstract 2
102000008212 P-Selectin Human genes 0.000 abstract 2
108010035766 P-Selectin Proteins 0.000 abstract 2
206010067484 Adverse reaction Diseases 0.000 abstract 1
206010015866 Extravasation Diseases 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
208000028389 Nerve injury Diseases 0.000 abstract 1
230000006838 adverse reaction Effects 0.000 abstract 1
230000015271 coagulation Effects 0.000 abstract 1
238000005345 coagulation Methods 0.000 abstract 1
230000007812 deficiency Effects 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000036251 extravasation Effects 0.000 abstract 1
230000004927 fusion Effects 0.000 abstract 1
102000037865 fusion proteins Human genes 0.000 abstract 1
108020001507 fusion proteins Proteins 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
230000000302 ischemic effect Effects 0.000 abstract 1
210000004165 myocardium Anatomy 0.000 abstract 1
230000008764 nerve damage Effects 0.000 abstract 1
230000008816 organ damage Effects 0.000 abstract 1
230000000241 respiratory effect Effects 0.000 abstract 1
208000011580 syndromic disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4727—Mucins, e.g. human intestinal mucin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Cell Biology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ARP960103147A 1995-06-14 1996-06-13 Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos. AR003436A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US21395P	1995-06-14	1995-06-14

Publications (1)

Publication Number	Publication Date
AR003436A1 true AR003436A1 (es)	1998-08-05

Family

ID=21690430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP960103147A AR003436A1 (es)	1995-06-14	1996-06-13	Ligandos de p-seletina y moleculas, acidos nucleicos purificados, vector, celula y uso de dichas moleculas para preparar medicamentos.

Country Status (14)

Country	Link
EP (1)	EP0833650A4 (cs)
JP (1)	JPH11508131A (cs)
KR (1)	KR19990022954A (cs)
AR (1)	AR003436A1 (cs)
AU (1)	AU6272996A (cs)
BR (1)	BR9608918A (cs)
CA (1)	CA2224625A1 (cs)
CZ (1)	CZ401497A3 (cs)
HU (1)	HUP9901131A2 (cs)
IL (1)	IL122590A0 (cs)
NO (1)	NO975862L (cs)
TR (1)	TR199701620T1 (cs)
WO (1)	WO1997000079A1 (cs)
ZA (1)	ZA965032B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999043834A2 (en) *	1998-02-27	1999-09-02	Genetics Institute, Inc.	P-selectin ligand protein, including tetrameric fusion proteins
EP1406930A4 (en) *	2000-12-29	2007-01-10	Savient Pharmaceuticals Inc	"ISOLATED MOLECULES WITH SULFATED GROUPING CONTAINING EPITOPES, ANTIBODIES AGAINST SUCH EPITOPES AND USES THEREOF"
JP4599027B2 (ja) *	2002-10-30	2010-12-15	東洋水産株式会社	Ｌ−セレクチン結合阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE224911T1 (de) *	1990-07-17	2002-10-15	Univ Oklahoma	Gmp-140 ligand
US5318890A (en) *	1991-05-06	1994-06-07	The Regents Of The University Of California	Assays for inhibitors of leukocyte adhesion
AU681369B2 (en) *	1992-11-16	1997-08-28	Board Of Regents Of The University Of Oklahoma, The	Glycoprotein ligand for P-selectin and methods of use thereof
WO1995030001A2 (en) *	1994-04-28	1995-11-09	Genetics Institute, Inc.	Novel p-selectin ligand protein

1996
- 1996-06-11 JP JP9503258A patent/JPH11508131A/ja active Pending
- 1996-06-11 EP EP96921519A patent/EP0833650A4/en not_active Withdrawn
- 1996-06-11 CZ CZ974014A patent/CZ401497A3/cs unknown
- 1996-06-11 BR BR9608918A patent/BR9608918A/pt not_active Application Discontinuation
- 1996-06-11 HU HU9901131A patent/HUP9901131A2/hu unknown
- 1996-06-11 IL IL12259096A patent/IL122590A0/xx unknown
- 1996-06-11 WO PCT/US1996/010043 patent/WO1997000079A1/en not_active Ceased
- 1996-06-11 CA CA002224625A patent/CA2224625A1/en not_active Abandoned
- 1996-06-11 AU AU62729/96A patent/AU6272996A/en not_active Abandoned
- 1996-06-11 KR KR1019970709424A patent/KR19990022954A/ko not_active Withdrawn
- 1996-06-11 TR TR97/01620T patent/TR199701620T1/xx unknown
- 1996-06-13 AR ARP960103147A patent/AR003436A1/es unknown
- 1996-06-13 ZA ZA965032A patent/ZA965032B/xx unknown
1997
- 1997-12-12 NO NO975862A patent/NO975862L/no unknown

Also Published As

Publication number	Publication date
JPH11508131A (ja)	1999-07-21
BR9608918A (pt)	1999-06-15
NO975862D0 (no)	1997-12-12
WO1997000079A1 (en)	1997-01-03
HUP9901131A2 (hu)	1999-07-28
ZA965032B (en)	1997-03-14
EP0833650A4 (en)	2005-01-19
CA2224625A1 (en)	1997-01-03
AU6272996A (en)	1997-01-15
CZ401497A3 (cs)	1998-07-15
NO975862L (no)	1998-02-12
TR199701620T1 (xx)	1998-05-21
KR19990022954A (ko)	1999-03-25
IL122590A0 (en)	1998-06-15
EP0833650A1 (en)	1998-04-08

Similar Documents

Publication	Publication Date	Title
Seenaiah et al.	2015	Convergent versus sequential protein synthesis: the case of ubiquitinated and glycosylated H2B
ES2094111T3 (es)	1997-01-16	Proteinas con actividad de factor viii, procedimiento para su produccion que utilizan celulas modificadas por ingenieria genetica y composiciones farmaceuticas que las contienen.
DK0720482T3 (da)	2004-06-21	Prosaposin og cytokin-afledte peptider som terapeutiske midler
ES2161885T3 (es)	2001-12-16	Sintesis de proteinas mediante ligacion quimica natural.
DE69427997D1 (de)	2001-09-20	Hybrider mensch/tier faktor viii
ES2147553T3 (es)	2000-09-16	Vectores virales recombinantes para la expresion en unas celulas musculares.
KR910012240A (ko)	1991-08-07	생물학적 활성 단백질의 제조방법
FI874819A0 (fi)	1987-11-02	Human rekombinant endotelcell vaextfaktor.
PT100245A (pt)	1993-07-30	Sequencia de adn que codifica um derivado de factor viii humano recombinante, biologicamente activo, vector de expressao recombinante, celula hospedeira, processo de producao de um derivado de factor vii e derivado de factor viii
HUP9801697A2 (hu)	1998-10-28	Új protein és eljárás előállítására
ES2165492T3 (es)	2002-03-16	Profarmacos ciclicos de peptidos y acidos nucleicos de peptidos con estabilidad metabolica mejorada y permeabilidad de la membrana celular.
DK0839154T3 (da)	2004-04-19	Biologiske aktive peptider og præparater samt anvendelse deraf
ATE183200T1 (de)	1999-08-15	Synthetische mischpeptide, die die entstehung von neutralisierenden antikörpern und die wirkung der cytotoxischen t-lymphozyten gegen hiv hervorufen
AR003427A1 (es)	1998-08-05	Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
KR930010177A (ko)	1993-06-22	하이브리드 형질전환 성장인자
HUP9900751A2 (hu)	1999-07-28	Parathormontartalmú stabil gyógyászati készítmény
Youssef	2009	On k-cordial labelling
Lorand et al.	1998	A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of γ chains by factor XIIIa
KR900701300A (ko)	1990-12-01	생물학적 활성 펩티드 및 특정음이온을 갖는 조성물 및 이것을 사용하는 방법
ATE6148T1 (de)	1984-02-15	Hexapeptide, deren herstellung, deren anwendung in arzneimitteln und sie enthaltende zusammensetzungen.
ES2155546T3 (es)	2001-05-16	Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y el uso de preparaciones farmaceuticas basadas en estos compuestos, asi como medicamentos que los contienen.
BR9607831A (pt)	1999-11-30	Vetor de açido nucleico, células de mamìferos, processos para a preparaçào de células e de uma proteìna de interesse, uso de um gene <225>-interferon humano, eritropoietina d humana ,e, composição farmacêutica.
ES2069272T3 (es)	1995-05-01	Hexapeptidos con grupos esteres sulfato.
MX9710114A (es)	1998-03-29	Ligandos de p-selectina y moleculas y metodos relacionados.
BR9104995A (pt)	1992-06-23	Complexos ligados em ponte a hidrogenio,processo para sua preparacao e preparacao farmaceutica